CORCEPT THERAPEUTICS INC (CORT) › Shareholders' EquityCORCEPT THERAPEUTICS INC (CORT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.1999: -$244.0K2000: -$2.00M2001: -$7.54M2002: -$21.94M2003: -$31.47M2004: $45.95M2005: $26.59M2006: $6.36M2007: $14.73M2008: $16.91M2009: $22.09M2010: $21.24M2011: $34.81M2012: $61.78M2013: $21.02M2014: -$3.39M2015: $18.50M2016: $41.38M2017: $190.97M2018: $275.88M2019: $371.18M2020: $523.34M2021: $375.81M2022: $501.84M2023: $506.70M2024: $679.59M2025: $647.80M$647.80M1999Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$647.80M-4.7%2024$679.59M+34.1%2023$506.70M+1.0%2022$501.84M+33.5%2021$375.81M-28.2%2020$523.34M+41.0%2019$371.18M+34.5%2018$275.88M+44.5%2017$190.97M+361.5%2016$41.38M+123.7%2015$18.50M+646.0%2014-$3.39M-116.1%2013$21.02M-66.0%2012$61.78M+77.5%2011$34.81M+63.8%2010$21.24M-3.8%2009$22.09M+30.7%2008$16.91M+14.7%2007$14.73M+131.7%2006$6.36M-76.1%2005$26.59M-42.1%2004$45.95M+246.0%2003-$31.47M-43.5%2002-$21.94M-191.0%2001-$7.54M-277.1%2000-$2.00M-719.3%1999-$244.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share